Delguste, Catherine ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Département clinique des animaux de compagnie et des équidés
Doucet, Michèle; Université de Montréal - UdeM > Biomédecine
Gabriel, Annick ; Université de Liège - ULiège > Département de morphologie et pathologie > Anatomie des animaux domestiques
Guyonnet, Jérôme; CEVA Santé Animale
Lepage, Olivier M; Université de Lyon > Département Hippique
Amory, Hélène ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Médecine interne des équidés
Language :
English
Title :
Assessment of a bone biopsy technique for measuring tiludronate in horses: A preliminary study
Publication date :
April 2011
Journal title :
Canadian Journal of Veterinary Research
ISSN :
0830-9000
Publisher :
Canadian Veterinary Medical Association, Ottawa, Canada
Denoix JM. Efficacy of tiludronate, a new bisphosphonate, in the treatment of navicular disease and bone spavin. A multicentric European clinical trial. Ippologia 2002;13:7-9.
Denoix JM, Thibaud D, Riccio B. Tiludronate as a new therapeutic agent in the treatment of navicular disease: A double-blind placebo-controlled clinical trial. Equine Vet J 2003;35:407-413.
Reginster JY. Oral tiludronate: Pharmacological properties and potential usefulness in Paget's disease of bone and osteoporosis. Bone 1992;13:351-354.
Cremers SC, Pillai G, Papapoulos SE. Pharmacokinetics/pharmacodynamics of bisphosphonates: Use for optimization of intermittent therapy for osteoporosis. Clin Pharmacokinet 2005;44:551-570.
Pillai G, Gieschke R, Goggin T, Jacqmin P, Schimmer RC, Steimer JL. A semimechanistic and mechanistic population PK-PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis. Br J Clin Pharmacol 2004; 58:618-631.
Delguste C, Amory H, Doucet M, et al. Pharmacological effects of tiludronate in horses after long-term immobilization. Bone 2007;41:414-421.
Delguste C, Amory H, Guyonnet J, et al. Comparative pharmacokinetics of two intravenous administration regimens of tiludronate in healthy adult horses and effects on the bone resorption marker CTX-1. J Vet Pharmacol Ther 2008;31:108-116.
Steiger R, Geyer H, Provencher A, Perron-Lepage M-F, Von Salis B, Lepage OM. Equine bone core biopsy: Evaluation of collection sites using a new electric drilling machine. Equine practice 1999;21:14-21.
Mashiba T, Hui S, Turner CH, Mori S, Johnston CC, Burr DB. Bone remodeling at the iliac crest can predict the changes in remodeling dynamics, microdamage accumulation, and mechanical properties in the lumbar vertebrae of dogs. Calcif Tissue Int 2005;77:180-185.
Alexiades MM, Boachie-Adjei O, Vigorita VJ. Histomorphometric analysis of vertebral and iliac crest bone samples. A correlated study. Spine 1990;15:286-288.
Thomsen JS, Ebbesen EN, Mosekilde L. Static histomorphometry of human iliac crest and vertebral trabecular bone: A comparative study. Bone 2002;30:267-274.
Chapurlat RD, Arlot M, Burt-Pichat B, et al. Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: A bone biopsy study. J Bone Miner Res 2007;22:1502-1509.
Lasseter KC, Porras AG, Denker A, Santhanagopal A, Daifotis A. Pharmacokinetic considerations in determining the terminal elimination half-lives of bisphosphonates. Clin Drug Investig 2005;25:107-114.
